Subcategory & Sub-subcategory
Product Name
Mirogabalin Besylate
Specifications
- CAS Number: 1138245-21-2
- Molecular Weight: 367.5
- Chemical Formula: C18H25NO5S
- Dosage Form: Oral film-coated tablet formulated for once- or twice-daily administration in neuropathic pain management.
- IUPAC Name: 2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acid;benzenesulfonic acid
- EC Number: 983-325-9
- Strength: Available in 2.5 mg, 5 mg, 10 mg, and 15 mg tablet strengths for titration to an effective, tolerated dose.
- Indication: Relief of peripheral neuropathic pain via selective binding to the alpha-2-delta subunit of central nervous system voltage-gated calcium channels, reducing abnormal nerve signaling.
- Regulatory Approval Status: The mirogabalin besylate molecule is approved in Japan (PMDA) for peripheral neuropathic pain and fibromyalgia; approval status elsewhere depends on local regulatory filings.
Leave your rating & comment